AUROPHARMA - Long Term Investment - Long - Nifty50 Script
Hi Friends,
We are going to Analysis the Pharma Stock which was Fundamentally Strong.
P/E was very attractive as per the Fundamental at 7.81 whereas the industries P/E was around 27.25.
Company ROE and ROCE for the last 5 Financial Year was above 20pct
PEG ratio was very low at 0.35
Company was debt free and capital growth for last 5 financial year was above 20pct
Let us analysis in the technical views.
we have witnessed the stock was in the bearish downtrend and EMA200 evidence the same in the Daily TF.
where as the script was flat range in weekly trend as per the EMA200.
In Monthly TF, the script was in the bullish view.
Support and Resistance:
In Monthly TF, the script has in the dynamic support of EMA50-EMA79 along with the FIB retracement level at 50% also the trendline act as the support.
In Weekly TF, the script has the support at 670 and 505 & resistance at 795, 898 and 1065 respectively.
Also the dynamic resistance at 832-873 as per EMA50-EMA72
In Daily TF, the script has support at 642-654 & Resistance at 728-752, 844-866, 976 & 1062.
Also the dynamic resistance at 861-889
Stochastic RSI in Daily and Weekly TF was in the oversold range whereas the 2hr TF was in the overbought range.
MACD of Daily, Weekly and 2hr TF was in the oversold range.
CPR in the daily TF was in the bearish bias and script brakes all the CPR S1-S3 and now retraced which act as the resistance.
ATR Volatility was shrinking as the powermove was already witnessed.
2HR TF Chart.
Technical Pattern was Bearish Flag Patter evidence and currently also the same was evidence.
whereas the script take support on EMA20 as dynamic support.
Based on the above, For Longterm view
script was one of the excellent script for wealth creation.
Based on the technical view,
Once the script invalidated the berish Flag in the 2HR go for Long - Only for Entry
SL - Below Flag Pattern - 1ATR on (Daily TF)
If like our analysis press the thumb-up button and comment your views.
We are going to Analysis the Pharma Stock which was Fundamentally Strong.
P/E was very attractive as per the Fundamental at 7.81 whereas the industries P/E was around 27.25.
Company ROE and ROCE for the last 5 Financial Year was above 20pct
PEG ratio was very low at 0.35
Company was debt free and capital growth for last 5 financial year was above 20pct
Let us analysis in the technical views.
we have witnessed the stock was in the bearish downtrend and EMA200 evidence the same in the Daily TF.
where as the script was flat range in weekly trend as per the EMA200.
In Monthly TF, the script was in the bullish view.
Support and Resistance:
In Monthly TF, the script has in the dynamic support of EMA50-EMA79 along with the FIB retracement level at 50% also the trendline act as the support.
In Weekly TF, the script has the support at 670 and 505 & resistance at 795, 898 and 1065 respectively.
Also the dynamic resistance at 832-873 as per EMA50-EMA72
In Daily TF, the script has support at 642-654 & Resistance at 728-752, 844-866, 976 & 1062.
Also the dynamic resistance at 861-889
Stochastic RSI in Daily and Weekly TF was in the oversold range whereas the 2hr TF was in the overbought range.
MACD of Daily, Weekly and 2hr TF was in the oversold range.
CPR in the daily TF was in the bearish bias and script brakes all the CPR S1-S3 and now retraced which act as the resistance.
ATR Volatility was shrinking as the powermove was already witnessed.
2HR TF Chart.
Technical Pattern was Bearish Flag Patter evidence and currently also the same was evidence.
whereas the script take support on EMA20 as dynamic support.
Based on the above, For Longterm view
script was one of the excellent script for wealth creation.
Based on the technical view,
Once the script invalidated the berish Flag in the 2HR go for Long - Only for Entry
SL - Below Flag Pattern - 1ATR on (Daily TF)
If like our analysis press the thumb-up button and comment your views.
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.